HAVCR2 and intrahepatic cholangiocarcinoma: In all individuals that were analyzed (both healthy controls (PCR and ICC) and RRMS patients (PCR)) TIM-3 was expressed in B cells (Supplementary Fig. 6) and on the surface of a small number of B cells (Supplementary Fig. 7).